ADDF presents vision of a consortium to accelerate research into speech and language biomarkers for Alzheimer's disease

(Alzheimer's Drug Discovery Foundation) In a commentary in Exploration in Medicine, Alzheimer's experts lay out a vision for a worldwide research consortium that can give clinicians -- and patients -- the answers to which speech and language changes may signal Alzheimer's in the form of digital biomarkers.